GlassScriptPhysician profile
Erin Maige Vickers
NPI 1831702760
$5,609.00
in general payments reported to CMS, 2019-2025
43 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $985 · 2022: $1,908 · 2023: $1,951 · 2024: $547 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,133.37 | 2021-2025 | |
| Nevro Corp. | $903.31 | 2021-2023 | Senza |
| Lundbeck LLC | $461.64 | 2021-2024 | Vyepti |
| Amgen INC. | $292.26 | 2021-2023 | Aimovig |
| Collegium Pharmaceutical, INC. | $262.05 | 2021-2024 | Belbuca, Xtampza |
| Lilly USA, LLC | $207.18 | 2021-2023 | Emgality |
| Teva Pharmaceuticals USA, INC. | $192.88 | 2022-2024 | Ajovy |
| Ucb, INC. | $186.16 | 2021-2023 | Briviact |
| Almatica Pharma LLC | $174.96 | 2021-2023 | Gralise |
| Grifols USA, LLC | $160.11 | 2022-2023 | Gamunex-C |
| Scilex Pharmaceuticals INC. | $149.35 | 2022-2023 | Ztlido |
| Medline Industries LP | $133.33 | 2025 | |
| Sk Life Science, INC. | $104.39 | 2022-2023 | |
| Neurelis, INC. | $102.41 | 2021-2024 | Valtoco |
| Genzyme Corporation | $102.09 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Vickers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.